Age, GVHD prophylaxis, and timing matter in thrombotic microangiopathy after haematopoietic cell transplantation—A secondary CIBMTR analysis

Documenti analoghi

• Fatal thrombotic microangiopathy during induction for acute myeloid leukemia: A case report and review of vascular complications in germline GATA2 haploinsufficiency
  di: Erin L. Frost, et al.
  Pubblicazione: (2024)
• Allogeneic haematopoietic cell transplantation in advanced systemic mastocytosis in the new era: A CIBMTR study
  di: Celalettin Ustun, et al.
  Pubblicazione: (2025)
• Endothelial activation and stress index score as a predictor of transplant‐associated thrombotic microangiopathy in patients with sickle cell disease
  di: Reethu Krishnan, et al.
  Pubblicazione: (2026)
• Evaluating tixagevimab/cilgavimab prophylaxis in allogeneic haematopoietic cell transplantation recipients for COVID‐19 prevention
  di: Julia Trepl, et al.
  Pubblicazione: (2024)
• Hydrometrocolpos secondary to vaginal GVHD in an adolescent patient
  di: Andrea Palasciano, et al.
  Pubblicazione: (2025)